Section 5: Reporting of changes, adverse events, and non-compliance
Policy 5.01
Topic: Amendments to approved research
Date of Implementation: April 13, 2009
Revised: August 28, 2012
Read moreAll changes in NAU IRB-approved
research protocols must be reported to the NAU IRB in writing using the
Research Amendment form. Examples of changes include:
- increase
or expansion of participant pool;
- addition
or alteration of data collection instruments;
- addition
of research personnel;
- alteration
in compensation to research participants;
- change
in recruitment plan;
- revision
of informed consent documents;
- any
other change that impacts participants, researchers, methodology,
confidentiality, or consent.
Investigator(s) submit the
Research Amendment form to the Human Protections Coordinator for review. If the
changes involve increasing risk to participants, the Amendment application may
be turned over to the fully convened board for review. Also, if the study was
originally approved under full board review, then the amendment must be
reviewed by the fully convened board at the next scheduled meeting.
If the changes are minor and do
not increase risk to participants and the application was not originally approved
under full board review, the change is approved by the Human Protections
Coordinator, who is a member of the board designated by the NAU IRB Chair to
review and approve studies qualifying for expedited review. Once the amendment
is approved, either by the Human Protections Coordinator or the fully convened
board, the investigator(s) will receive an approval letter for the change via
email. The investigator must not initiate the changes in the research protocol
prior to receiving the amendment approval letter from the Human Protections
Coordinator. Non-compliance with this policy will be handled on a case by case
basis.
Policy 5.02
Topic: Adverse events
Date of implementation: April 13, 2009
Revised: August 28, 2012
Read moreAny adverse event is any
injury, trauma, or illness experienced by a participant that required medical
or psychological treatment or had the potential to require medical or
psychological treatment. Investigators are required to report adverse events
that were not anticipated and therefore not listed on the consent form. Any
risks that were listed on the consent form do not constitute adverse events and
do not have to be reported to the IRB.
Unanticipated problems
involving risks to participants or others are:
- unexpected
in terms of nature, severity, or frequency given (a) the research procedures
that are described in the protocol-related documents, such as the IRB-approved
research protocol and informed consent document; and (b) the characteristics of
the subject population being studied;
- related
or possibly related to participation in the research, meaning that there is a
reasonable possibility that the incident, experience, or outcome may have been
caused by the procedures involved in the research; and
- indicators
that the research places subjects or others at a greater risk of harm,
including physical, psychological, economic, or social harm, than was
previously known or recognized.
The PI (or LI with faculty
sponsorship) must make the initial determination that the event is an
unanticipated problem involving risks to others. Unanticipated problems and
unexpected adverse events experienced by a research participant must be
reported to the IRB within 5 business days of the researcher becoming aware of
them by filling out the Adverse Reaction and Event reporting form. The form
should be submitted to the Human Protections Coordinator, who will report it to
the IRB Chair, Institutional Official, US Office of Human Research Protection,
and any funding agencies. All aspects of the research project must be halted
until further notice from the IRB. Non-compliance with this policy will be
handled on a case by case basis.
Policy 5.03
Topic: Serious adverse events
Date of implementation: April 13, 2009
Revised: August 28, 2012
Read moreA serious adverse event, as
defined by the OHRP “Guidance on Reviewing and Reporting Unanticipated Risks to
Subjects or Others and Adverse Events” (see http://www.hhs.gov/ohrp/policy/advevntguid.html),
is any adverse event that:
- results
in death;
- is
life-threatening (places the participant at immediate risk of death from the
event as it occurred);
- results
in inpatient hospitalization or prolongation of existing hospitalization;
- results
in a persistent or significant disability/incapacity;
- results
in congenital anomaly/birth defect; or
- based
upon appropriate medical judgment, may jeopardize the participant’s health and
may require medical or surgical intervention to prevent one of the other
outcomes listed in this definition.
A serious adverse event must be
reported to the IRB within 24 hours of the researcher becoming aware of it.
Using the Adverse Reaction and Event reporting form, the PI describes the
nature of the event, the medical treatment that the participant received, the
likelihood that the event was related to the research protocol, and any changes
in the protocol or informed consent that are needed to protect other subjects.
A consulting physician must also comment on the severity of the event and the
likelihood that it was related to the research protocol. The form should be
submitted to the Human Protections Coordinator, who will report it to the NAU IRB
Chair, Institutional Official, US Office of Human Research Protection, and any
funding agencies. All aspects of the research project must be halted until
further notice from the NAU IRB. Non-compliance with this policy will be
handled on a case by case basis.
Policy 5.04
Topic: Failure to seek IRB approval
Date of implementation: April 13, 2009
Read moreThe IRB requires the review and approval of all research
protocols involving human research participants prior to recruitment or contact
of potential participants or the collection of data. Researchers who do not
comply with this requirement will have their research halted by the IRB.
Any person can make an allegation of non-compliance with
this requirement. The IRB will seek information concerning allegations of
non-compliance by any Northern Arizona University student, faculty, or staff.
If non-compliance has occurred, the board will determine if the non-compliance
was due to lack of knowledge or awareness of the requirement or if it was due
to a knowing and willful disregard of the requirement.
The IRB may forward its findings to other disciplinary committees
at Northern Arizona University with its recommendations for sanctions.
Sanctions for failure to receive IRB approval for research involving human
participants range from a written reprimand to disallowing all further research
projects at Northern Arizona University.
The IRB may also prohibit the use of all data collected
prior to the IRB review and approval. Non-compliance with this policy will be
handled on a case by case basis.
Policy 5.05
Topic: Follow-up to complaints of non-compliance
Date of implementation: April 13, 2009
Read moreAll researchers conducting human subjects research are
expected to conduct research within the guidelines of 45 CFR 46. Any person can
make an allegation of non-compliance with this requirement. Researchers may be
subject to sanctions if his/her project falls out of compliance. Disciplinary
action by the IRB may include, depending on the severity of the infraction:
- a written reprimand
- suspension of the research project
- termination of the project
- suspension of all future research conducted by
the individual researcher
- seizure of all research data
At a minimum, the occurrence of non-compliance will be
documented by the Human Protections Coordinator using the Internal Incident
Report, filed with the researcher’s IRB materials in the IRB office. The report
may or may not be shared with the researcher’s departmental chair or college
dean.
These policies and related procedures are described here in
compliance with the Code of Federal Regulations, Title 45, Part 46.103(b)(4)
and 46.103(b)(5)